candesartan has been researched along with Hematoma in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We assessed the effects of treatment with candesartan in acute ICH and according to different types of hematoma." | 9.30 | Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage. ( Anderson, C; Bath, PM; Berge, E; Berge, TE; Delcourt, C; Guo, R; Jusufovic, M; Karlson, BW; Sandset, EC; You, S, 2019) |
| " We assessed the effects of treatment with candesartan in acute ICH and according to different types of hematoma." | 5.30 | Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage. ( Anderson, C; Bath, PM; Berge, E; Berge, TE; Delcourt, C; Guo, R; Jusufovic, M; Karlson, BW; Sandset, EC; You, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jusufovic, M | 1 |
| Berge, TE | 1 |
| Guo, R | 1 |
| You, S | 1 |
| Delcourt, C | 1 |
| Anderson, C | 1 |
| Bath, PM | 1 |
| Karlson, BW | 1 |
| Berge, E | 1 |
| Sandset, EC | 1 |
1 trial available for candesartan and Hematoma
| Article | Year |
|---|---|
Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimida | 2019 |